newsfilter
← Latest News
Business Wire·

Ipsen Delivers Encouraging Sales Growth in the First Quarter of 2021 Despite the Pandemic, and Confirms Its Full-Year Guidance

Regulatory News: Ipsen ((Euronext: IPN, OTC:IPSEY), a global specialty-driven biopharmaceutical group, publishes its sales performance for the first quarter of 2021: Q1 2021 sales summary(unaudited IFRS consolidated sales) Q